Related by context. All words. (Click for frequent words.) 79 Paraplatin ® 76 Pemetrexed 74 Hormone Refractory Prostate Cancer 74 Pegylated Interferon 74 metastatic malignant 74 Peginterferon 73 DOXIL 73 thalidomide Thalomid 73 alfa 2a 73 Camptosar ® 73 Prolongs Survival 73 5 Fluorouracil 73 Lenalidomide 73 Gemzar ® 73 Doxil ® 72 Investigational Treatment 72 erlotinib Tarceva ® 72 Gemcitabine 72 Adjuvant Treatment 72 Interferon beta 1a 72 FASLODEX 72 Bevacizumab 72 SPRYCEL ® 72 cisplatin gemcitabine 72 paclitaxel Taxol ® 72 paclitaxel Taxol R 72 Pegylated Liposomal Doxorubicin 72 docetaxel Taxotere ® 72 gemcitabine Gemzar 72 Irinotecan 71 Adjuvant Chemotherapy 71 Advanced Melanoma 71 Capecitabine 71 relapsed MM 71 Improves Outcomes 71 Fludarabine 71 Neoadjuvant 71 5 FU leucovorin 71 abacavir Ziagen 71 gemcitabine carboplatin 71 Patients Receiving 71 Nilotinib 71 adalimumab Humira 71 Patients Treated With 71 AVASTIN 71 Peginterferon Alfa 2a 71 Cytarabine 71 certolizumab 71 sorafenib Nexavar 71 gefitinib Iressa 71 Cyclophosphamide 71 Platinol ® cisplatin 70 adriamycin 70 Fulvestrant 70 Fluorouracil 70 Meets Primary Endpoint 70 ara C 70 temozolomide Temodar 70 pegylated interferon alfa 70 pegylated liposomal doxorubicin 70 peginterferon alpha 2a 70 Etanercept 70 Newly Diagnosed Multiple Myeloma 70 Navelbine ® 70 dasatinib Sprycel ® 70 Myelodysplastic Syndrome MDS 70 MGd 70 Metastatic Colorectal Cancer 70 Retreatment 70 neurologic progression 70 Antitumor Activity 70 Interferon Alfa 70 PEGINTRON TM 70 mycophenolate mofetil 70 Adjuvant Therapy 70 Mitoxantrone 70 Interferon Beta 70 alpha 2a 70 FOLFOX4 70 gemcitabine cisplatin 70 refractory chronic lymphocytic 70 ABVD 70 standard chemotherapy regimen 70 Peg IFN 70 ribavirin Copegus ® 70 Treated Patients 70 Aflibercept 70 Tiotropium 69 fluorouracil 69 Severe Sepsis 69 Zorbtive TM 69 sargramostim 69 Leucovorin 69 fluvastatin 69 Study Evaluating 69 CHOP chemotherapy 69 ORENCIA ® 69 Paraplatin ® carboplatin 69 pyrazinamide 69 FDA Approvals 69 Diabetic Neuropathy 69 Relapsing Multiple Sclerosis 69 peginterferon alfa 2a Pegasys 69 bevacizumab Avastin ® 69 Chemoradiation 69 epoetin alpha 69 Intravitreal 69 Ziprasidone 69 ribavirin RBV 69 8mg/kg 69 CANCIDAS 69 efalizumab 69 Metastatic Prostate Cancer 69 Vidaza azacitidine 69 ritonavir boosted 69 cyclophosphamide methotrexate 69 biologic DMARD 69 Phase 2b Trial 69 Xelox 69 Metastatic Renal Cell Carcinoma 69 gemcitabine chemotherapy 69 Pegasys peginterferon alfa 2a 69 ACE Inhibitors 69 Dasatinib 69 PegIFN RBV 69 5 fluorouracil leucovorin 69 MAGE A3 ASCI 69 Complicated Skin 69 Alkeran 69 See CLINICAL PHARMACOLOGY 69 Toxicities 69 fludarabine cyclophosphamide 69 PEGASYS ® 69 Azathioprine 69 Decitabine 69 Single Dose 69 Degarelix 69 Danazol 69 Moxifloxacin 69 salmeterol fluticasone 69 Erlotinib 69 Neulasta ® 69 Trastuzumab 69 Interferon alfa 69 FUSILEV enhances 69 bevacizumab Avastin 69 Demonstrates Efficacy 69 TAXOTERE R 69 Improves Survival 69 Folfox 69 pegylated interferon alfa 2a 69 Mycophenolate Mofetil 69 Pegasys ® 69 nicardipine 69 FOLFIRI 69 efavirenz EFV 69 Naive Patients 69 estramustine 69 Cutaneous T 69 Oxaliplatin 68 fluticasone salmeterol 68 Teva Provides Update 68 azacytidine 68 Fondaparinux 68 nimodipine 68 letrozole Femara 68 mitoxantrone plus 68 Shows Statistically Significant 68 R Saizen R 68 Xeloda ® 68 etanercept Enbrel 68 FOLFOX6 68 Nebulized 68 Bosutinib 68 paclitaxel Taxol 68 zonisamide SR 68 Unresectable 68 interferon alfa 2b 68 Phase IIb Clinical Trial 68 alfuzosin 68 gemtuzumab ozogamicin 68 5-FU/LV 68 Adjunctive Therapy 68 Natalizumab 68 Phase 2b Clinical Trial 68 Peginterferon alfa 2b 68 Allogeneic 68 dual endothelin receptor antagonist 68 Drug Candidate 68 Taxol paclitaxel 68 Fludara ® 68 Initiate Clinical Trial 68 Kepivance 68 bacillus Calmette Guerin 68 insulin glulisine 68 Pharmacokinetics PK 68 Melphalan 68 Anthracycline 68 Temodar ® 68 cetuximab Erbitux ® 68 busulfan 68 relapsing multiple sclerosis 68 cinacalcet 68 leukemia AML 68 bortezomib Velcade 68 Vidaza ® 68 abacavir lamivudine 68 Castration Resistant Prostate Cancer 68 Long Term Efficacy 68 basiliximab 68 GW# [003] 68 RAPAMUNE 68 Antiangiogenic 68 Parathyroid Hormone 68 chemoradiation therapy 68 ribavirin USP 68 lapatinib Tykerb 68 cysteamine bitartrate 68 Bortezomib 68 Neupogen ® 68 Azacitidine 68 paroxetine sertraline 68 4mg/kg 68 NDA Submission 68 Previously Untreated 68 FIRMAGON 68 Renal Insufficiency 68 peginterferon alfa 68 docetaxel Taxotere 68 Inhalation Solution 68 interferon gamma 1b 68 colesevelam HCl 68 pegylated IFN 68 Gemzar gemcitabine 68 Survival Benefit 68 Combination Treatment 68 Lupus Nephritis 68 Idiopathic Pulmonary Fibrosis 68 Improved Survival 68 hormone refractory metastatic prostate 68 interferon alfa 2a 68 pegfilgrastim 68 Patients Treated 68 Toremifene 68 beta 1a 68 oxaliplatin Eloxatin 68 Copegus ribavirin 68 Chronic Renal Failure 68 pemetrexed Alimta 68 Hycamtin ® 68 dexamethasone Decadron 68 tamoxifen Nolvadex ® 68 PEGylated Fab fragment 68 Flu Cy 68 Inhaled Corticosteroids 68 Bezielle 68 daunorubicin 68 Posaconazole 68 PEG IFN 68 Temsirolimus 68 Efficacy Trial 68 vorinostat 68 anthracycline taxane 68 CAELYX 68 Epratuzumab 68 Soft Tissue Sarcoma 68 aspirin clopidogrel 68 Initiates Clinical Trial 67 Pediatric Patients 67 dasatinib Sprycel 67 Bivalirudin 67 Rheumatoid Arthritis Patients 67 Pooled Analysis 67 mycophenolate mofetil MMF 67 Soriatane 67 Antipsychotic 67 Pulmonary Arterial Hypertension 67 denileukin diftitox 67 oral clodronate 67 cidofovir 67 Investigational Compound 67 TNF Tumor Necrosis Factor 67 Unfractionated Heparin 67 unfractionated heparin UFH 67 Nesiritide 67 Follicular Lymphoma 67 mitomycin 67 Clolar ® 67 Transdermal Patch 67 Allergic Rhinitis 67 Inhalation Aerosol 67 doxorubicin cyclophosphamide 67 INCB# [003] 67 temsirolimus Torisel 67 steroid dexamethasone 67 melphalan prednisone 67 moderate renal impairment 67 alefacept 67 sunitinib Sutent 67 Chronic Hepatitis C 67 Advanced Prostate Cancer 67 Taxol ® 67 Efficacy Results 67 Trabectedin 67 arsenic trioxide injection 67 APTIVUS 67 Androgen Deprivation Therapy 67 microtubule inhibitor 67 ACTEMRA TM 67 Helicobacter pylori eradication 67 INVANZ 67 Thalomid ® 67 candesartan cilexetil 67 Medoxomil 67 Pertuzumab 67 ALN HPN 67 Receives Orphan Drug Designation 67 Ranolazine 67 Mitomycin C 67 NOLVADEX 67 Plus Ribavirin 67 AVONEX ® 67 venlafaxine Effexor 67 Fluticasone 67 Taxotere chemotherapy 67 Adjuvant chemotherapy 67 platelet inhibitor 67 cyclophosphamide doxorubicin vincristine 67 imatinib Gleevec ® 67 Glufosfamide 67 Orally administered 67 Treatment Resistant 67 Novel Oral 67 GLIADEL R Wafer 67 PSMA ADC 67 tinidazole 67 Vandetanib 67 Clinical Trial Evaluating 67 Intravesical 67 docetaxel Taxotere R 67 Copegus ® 67 epoetin beta 67 divalproex sodium 67 flutamide 67 Aliskiren 67 dacarbazine DTIC 67 lexidronam injection 67 mycophenolic acid 67 HER2 Positive Breast Cancer 67 STELARA TM 67 TYGACIL 67 Eli Lilly Gemzar 67 Antiplatelet 67 boosted protease inhibitor 67 NSABP B 67 Treatment Naive Patients 67 BEXXAR Therapeutic Regimen 67 fluorouracil leucovorin 67 postoperative chemotherapy 67 Monotherapy 67 immunosuppressive regimen 67 Renal Function 67 Refractory Hodgkin Lymphoma 67 Taxane 67 INTEGRILIN R 67 sunitinib Sutent ® 67 Bosentan 67 induced macular edema 67 Myelofibrosis 67 Glatiramer acetate 67 vincristine doxorubicin 67 Bicalutamide 67 trastuzumab Herceptin R 67 Plaquenil 67 Bevacizumab Avastin 67 carmustine 67 Corticosteroid 67 Prophylactic Treatment 67 Mg Usa 67 ® lenalidomide 67 plus dexamethasone 67 Ranibizumab 67 Cloretazine 67 Renal Impairment 67 clopidogrel Plavix 67 icatibant 67 Dacogen decitabine 67 Taxotere ® 67 cetuximab Erbitux R 67 JAK Inhibitor 67 cisplatin chemotherapy 67 Pfizer Camptosar 67 Leukine ® 67 Severe Asthma 67 Parnate 67 Novantrone 67 SIMCOR 67 cisplatin carboplatin 67 Reduces Mortality 67 erlotinib Tarceva 67 Exemestane 67 Demonstrates Significant 67 ACE Inhibitor 67 Tacrolimus 67 ARCOXIA 67 Patients Undergoing 67 Demonstrate Significant 67 herpetic keratitis 67 miconazole Lauriad ® 67 ZOLINZA 67 Atypical Hemolytic Uremic Syndrome 67 Dose Ranging Study 67 HYCAMTIN 67 Pegylated interferon 67 Phase IIb Trial 67 myelodysplastic myeloproliferative diseases 67 Seliciclib 67 Hypercholesterolemia 67 Previously Treated 67 donepezil Aricept 67 PEGylated anti 67 Predict Response 67 Velcade bortezomib 67 folinic acid 66 Unstable Angina 66 alkylating agent 66 low dose cytarabine 66 COPEGUS R 66 FOLFOX6 chemotherapy regimen 66 infusional 66 chemotherapy FOLFOX 66 Protease Inhibitor 66 alpha interferons 66 CIMZIA ™ 66 Abciximab 66 Traficet EN 66 Bronchiectasis 66 oral Hycamtin 66 Ophena TM 66 Platinol 66 Elderly Patients 66 Renal Cell Carcinoma 66 dalteparin 66 GP IIb IIIa inhibitors 66 ZACTIMA 66 Schizophrenia Treatment 66 HDAC Inhibitor 66 beclomethasone dipropionate 66 targeted radiotherapeutic 66 briakinumab 66 receiving prophylactic anticoagulation 66 somatostatin analogues 66 Cimzia TM 66 Elitek 66 zoledronate 66 calcineurin inhibitor 66 Alpha interferons including 66 Completes Patient Enrollment 66 tigecycline 66 Zarnestra 66 PENTASA 66 Warfarin Coumadin 66 non resectable 66 concurrent chemoradiation 66 Juvenile Idiopathic Arthritis 66 Epirubicin 66 visilizumab 66 Node Positive 66 metastatic hormone refractory 66 rituximab Rituxan 66 bevacizumab Avastin R 66 Tezampanel 66 oblimersen 66 pamidronate 66 Teriflunomide 66 Teriparatide 66 R lenalidomide 66 Study Demonstrates 66 Glatiramer Acetate 66 Anti Tumor 66 Cardiotoxicity 66 Neulasta R 66 Controlled Trial 66 Filgrastim 66 vapreotide acetate 66 Pivotal Phase III 66 Leukemias 66 IND Application 66 Autologous Stem Cell Transplantation 66 Heterozygous Familial Hypercholesterolemia 66 Panzem R 66 PKC# 66 haematologic 66 imatinib Gleevec 66 Pivotal Study 66 Phase Ib Clinical Trial 66 peginterferon alfa 2a #KD 66 efaproxiral 66 epirubicin 66 liposomal amphotericin B 66 Carboplatin 66 Oxybutynin 66 Hormone Receptor Positive 66 TAXOTERE ® 66 NMIBC 66 Betaferon R 66 Ozarelix 66 Well Tolerated 66 Localized Prostate Cancer 66 ethambutol 66 Myelodysplastic Syndrome 66 Investigational Agent 66 pegylated interferon alfa 2b 66 antithymocyte globulin 66 gemcitabine Gemzar ® 66 bendamustine 66 Mg Uk 66 HuMax 66 angiotensin converting enzyme inhibitors 66 pegylated interferon alpha 66 Chronic Sinusitis 66 Etoposide 66 oral beclomethasone dipropionate 66 metastatic GIST 66 Relapsing Remitting Multiple Sclerosis 66 Partial Onset Seizures 66 Cervical Dystonia 66 inhalation powder 66 Relapsed Refractory 66 trastuzumab Herceptin 66 superficial bladder cancer 66 vinca alkaloid 66 interferon alfa 66 doxorubicin HCl liposome injection 66 fluoropyrimidine 66 Caelyx 66 weekly subcutaneous injections 66 methotrexate monotherapy 66 AZT zidovudine Retrovir 66 Pazopanib 66 CIMZIA R 66 BEACOPP 66 azacitidine 66 APTIVUS r 66 HCV Genotype 66 invasive candidiasis 66 Malignant Glioma 66 CLINICAL PHARMACOLOGY 66 haematologic malignancies 66 lenalidomide Revlimid 66 IV Busulfex 66 Double Blind Randomized 66 #mg/#mg 66 peginterferon alfa 2a 66 somatostatin analog 66 lenalidomide Revlimid R 66 capecitabine Xeloda 66 metastatic castration resistant 66 trastuzumab Herceptin ® 66 Noxafil 66 recurrent NSCLC 66 dextromethorphan quinidine 66 Preclinical Data 66 Ixempra 66 Combination therapy 66 ARIMIDEX 66 Tyrosine Kinase Inhibitor 66 Estrogen Receptor 66 prostate cancer HRPC 66 KAPIDEX 66 ARIXTRA R 66 Heart Failure Patients 66 Oral Fingolimod 66 liposomal formulation 66 Protease Inhibitors 66 Eculizumab 66 Tyrosine Kinase Inhibitors 66 Neovascular Age Related Macular 66 Perforomist ™ Inhalation Solution 66 Demonstrates Positive 66 Sanofi Aventis Taxotere 66 anthracyclines taxanes 66 doxazosin 66 Quinamed 66 Launches Generic Version 66 Is Well Tolerated 66 paclitaxel poliglumex 66 ISTODAX ® 66 Oral Mucositis 66 ixabepilone 66 Demonstrates Sustained 66 Panzem R NCD 66 Vinorelbine 66 NAVISTAR R 66 mg/m2 dose 66 5-fluorouracil/leucovorin 66 administered concomitantly 66 FluCAM arm 66 Hematologic 66 Neoadjuvant Chemotherapy 66 mitoxantrone chemotherapy 66 FOR FURTHER INFORMATION ABOUT 66 Diabetic Nephropathy 66 Cetuximab Erbitux 66 Anti Tumor Activity 66 histone deacetylase HDAC inhibitor 66 Tarceva TM 66 Advanced Renal Cell 66 Study Showed 66 oral levofloxacin 66 Pivotal Phase 66 systemic corticosteroid 66 Diffuse Large B 66 Dabigatran 66 corticosteroid dexamethasone 66 Tolerability 66 Fluconazole 66 Syncria R 66 Percutaneous Tibial Nerve Stimulation 66 Adefovir 66 QVAR ® 66 Cell Lymphoma CTCL 66 leukotriene receptor antagonist 66 Interferon Alpha 66 liposome injection 66 Alemtuzumab 66 pioglitazone HCl 66 RAPTIVA 66 plus prednisone 66 Deforolimus 66 danazol 66 paroxetine Paxil 66 sunitinib malate 66 TPV r 66 Hazard Ratio 66 Pafuramidine 66 Budesonide 66 AMEVIVE 66 galiximab 66 mg kg BID 66 rizatriptan 66 BENICAR HCT 66 Hydrochlorothiazide 66 metformin sulfonylurea 66 Interferon beta 66 Oral Cladribine 66 PEG interferon 65 Phase 2b Study 65 Pegylated 65 Safinamide 65 cromolyn sodium 65 Radioimmunotherapy 65 comparator arm 65 dacarbazine 65 LEUKINE 65 liposomal doxorubicin 65 piroxicam 65 Lubiprostone 65 paclitaxel cisplatin 65 mRCC 65 trabectedin 65 DOXIL ® 65 Saforis 65 ORENCIA R 65 Granted Orphan Drug 65 Omacetaxine 65 Ridaforolimus 65 achieved CCyR 65 infliximab monotherapy 65 Chemotherapy Induced 65 Femara letrozole 65 CLL SLL 65 Invasive Breast Cancer 65 transdermal estradiol 65 Trastuzumab Herceptin 65 Motexafin Gadolinium 65 carboplatin paclitaxel 65 bortezomib Velcade R 65 Immunomodulatory 65 glatiramer acetate 65 BARACLUDE ® 65 pegylated interferons 65 Progressive Multifocal Leukoencephalopathy 65 YONDELIS 65 stage IIIB 65 rasagiline tablets 65 Knee Osteoarthritis 65 Phase III Clinical Trial 65 Hyperlipidemia 65 CHARM Added 65 ALVESCO ® 65 Selective Internal 65 Tigecycline 65 Solid Tumors 65 Adalimumab 65 Anticancer Drug 65 epirubicin cisplatin 65 Demonstrates Potential 65 PROCRIT ® 65 formoterol fumarate 65 adefovir dipivoxil 65 FS Antihemophilic Factor Recombinant 65 Plaque Psoriasis 65 recurrent glioblastoma multiforme 65 BENICAR 65 Prospective Randomized 65 TEMODAL 65 Chronic Bronchitis 65 interferon therapy 65 Overactive Bladder 65 Placebo Controlled Trial 65 Retinal Vein Occlusion 65 Daptomycin 65 lipid lowering agents 65 Investigational Oral 65 Bisphosphonate 65 Anti TNF 65 CIMZIA TM certolizumab pegol 65 saline placebo 65 Shows Promise Against 65 estrogen receptor antagonist 65 CONTRAINDICATIONS 65 sorafenib tablets 65 Boceprevir 65 betamethasone dipropionate 65 epoprostenol 65 aripiprazole Abilify 65 Diabetic Foot Ulcer 65 Myelodysplastic Syndromes 65 Lenocta 65 Replacement Therapy 65 epirubicin cyclophosphamide 65 pertuzumab 65 PEGylated interferon beta 1a 65 idarubicin 65 Hepatitis C Genotype 65 Maribavir 65 voriconazole 65 Alocrest 65 Darunavir 65 Cremophor 65 monoclonal antibody conjugated 65 Coronary Artery Bypass Graft 65 paclitaxel carboplatin 65 orally administered inhibitor 65 Novel Inhibitor 65 SinuNase TM 65 risedronate Actonel 65 Desvenlafaxine Succinate 65 Combo Therapy 65 PegIntron 65 biliary tract cancer 65 sipuleucel T 65 GnRH agonists 65 cell lymphoma CTCL 65 Demonstrates Potent 65 receiving INTRON 65 Non Responders 65 Levoleucovorin 65 chlorambucil 65 Solid Tumors criteria 65 Hsp# Inhibitor 65 Antitumor 65 Ecallantide 65 Known hypersensitivity 65 goserelin 65 Romiplostim 65 Shows Efficacy 65 tazobactam 65 Aurora Kinase 65 Epoetin 65 Pharmacokinetic Study 65 plus prednisone prednisolone 65 ritonavir boosted atazanavir 65 Initiates Clinical 65 sertraline Zoloft 65 fallopian tube carcinoma 65 Treatment Naïve 65 Showed Significant 65 ribavirin therapy 65 Bendamustine 65 direct thrombin inhibitors 65 inhibitor RG# 65 amoxicillin clavulanate 65 ER CHOP 65 ULORIC 65 Aptivus ® 65 Montelukast 65 demonstrated antitumor activity 65 partial remissions 65 dimeglumine 65 acyclovir Lauriad R 65 Topotecan 65 DEXILANT 65 receptor tyrosine kinase inhibitor 65 Cisplatin 65 nitroprusside 65 PEGylated interferon 65 docetaxel chemotherapy 65 oral antidiabetic medication 65 essential thrombocythemia ET 65 Reduced Risk 65 Sprycel dasatinib 65 CYT# potent vascular disrupting 65 deep venous thromboses 65 tacrolimus ointment 65 drotrecogin alfa activated 65 TELINTRA 65 VELCADE melphalan 65 Carbamazepine 65 Acute Ischemic Stroke 65 verteporfin 65 cis retinoic acid 65 Vildagliptin 65 MYCAMINE 65 interferon ribavirin 65 interferon alpha IFN alpha 65 tipranavir r 65 ziprasidone Geodon 65 severe neutropenia 65 Gleevec imatinib mesylate 65 ZYVOX 65 Gliadel Wafer 65 Antiviral Activity 65 doxorubicin docetaxel 65 Rifampin 65 sitagliptin metformin 65 Adjunctive 65 sorafenib Nexavar ® 65 Quetiapine 65 protease inhibitor PI 65 Ibritumomab Tiuxetan 65 prucalopride 65 olmesartan 65 chemotherapy cisplatin 65 Bipolar Mania 65 prednisone prednisolone 65 Bronchodilator 65 NATRECOR ® 65 lymphoid malignancies 65 Hepatocellular Carcinoma 65 baminercept 65 Advanced Solid Tumors 65 Thal Dex 65 omalizumab Xolair 65 Amrubicin 65 Doxorubicin 65 Sanofi Pasteur Fluzone 65 Mouse Model 65 Statistically Significant 65 rFSH 65 mapatumumab 65 malignant pleural mesothelioma MPM 65 Investigational Drug 65 Bazedoxifene 65 octreotide LAR 65 Tumor Response 65 Navelbine 65 EFFEXOR XR 65 caspofungin 65 mitomycin C 65 antimetabolite 65 Pegloticase 65 FOLFOX chemotherapy 65 Triptan 65 salmeterol fluticasone propionate 65 topical gel formulation 65 Relapsed Refractory Multiple Myeloma 65 Valopicitabine 65 Phase 2a Clinical Trial 65 SUPPRELIN R LA 65 overactive bladder syndrome 65 selective modulator 65 Phase IIa Clinical Trial 65 micafungin 65 metastatic neuroendocrine tumors 65 Amgen Neulasta R 65 receiving highly emetogenic 65 E1 INT TM 65 Secondary Hyperparathyroidism 65 Pivotal Trial 65 CTAP# 65 octreotide acetate 65 treat chronic sinusitis 65 Taxotere docetaxel 65 Xcytrin R 65 Venlafaxine 65 Liposomal 65 Eraxis 65 Cilostazol 65 decitabine 65 Doxil 65 hA# 65 Anti Bacterial Envelope 65 LHRH agonists 65 forodesine 65 trans retinoic acid 65 haloperidol Haldol 65 Abrupt discontinuation 65 TLK# 65 Fast Track Status 65 EOquin TM 65 Squamous 65 Dyloject TM 65 sitagliptin Januvia 65 abiraterone acetate 65 Carbidopa Levodopa 65 Campath alemtuzumab 65 tolterodine ER 65 Pegintron 65 NeuroSTAT ® 65 Intrathecal 65 Tanespimycin 65 G#DT 65 Phase III Trial 65 palifermin 65 Interferon alpha 65 Presents Preclinical Data 65 β blockers 65 concomitant medications 65 Telithromycin 65 INTELENCE 65 TO AVOID PREGNANCY WHILE 65 Combination REOLYSIN R 65 QD dosing 65 Amplimexon 65 intranasal formulation 65 Certolizumab pegol 65 Acute Coronary Syndromes 64 complement inhibitor eculizumab 64 CTAP# Capsules 64 citalopram Celexa 64 Sustained Efficacy 64 Achieves Primary Endpoint 64 CIMZIA TM 64 Phase IIa Trial 64 angiotensin converting enzyme inhibitor 64 Aerosolized 64 MKC# MT 64 Exacerbation 64 Clostridium difficile Infection 64 Sevelamer 64 prospectively stratified 64 Cytoxan 64 Enoxaparin 64 gastrointestinal stromal tumors GIST 64 antiandrogens 64 Tipranavir 64 G CSFs 64 Catena ® 64 achieved ACR# 64 5FU 64 Virologic 64 Iluvien TM 64 6 mercaptopurine 64 ST Elevation Myocardial 64 Seasonal Allergic Rhinitis 64 Elotuzumab 64 Randomized Evaluation 64 Benign Prostatic Hyperplasia 64 Metastatic Melanoma 64 Myocet 64 Septic Shock 64 chemoradiotherapy 64 pomalidomide 64 Sandostatin R 64 adjuvant tamoxifen 64 brand ciclesonide HFA 64 metastatic CRC 64 Disease Modifying 64 tenofovir emtricitabine 64 glulisine 64 Antigen Specific 64 aspirin heparin 64 piperacillin tazobactam 64 evaluating tivozanib 64 octreotide implant 64 Ramipril 64 Gefitinib 64 lenalidomide dexamethasone 64 baseline LDH 64 xanthine oxidase inhibitor 64 Trial Evaluating 64 Valsartan 64 severe renal impairment 64 Infusion Reactions Severe 64 sitaxsentan 64 ReoPro 64 OvaRex ® MAb 64 Recurrent Breast Cancer 64 TORISEL 64 meropenem 64 bleomycin 64 RELOVAIR ™ 64 stage IIIb IV 64 INSPIRE Trial Phase III 64 q8h 64 rosuvastatin Crestor 64 STELARA ™